Gilead Cancels Midstage HIV Trial as FDA Clinical Hold Remains Intact on April 02, 2026 CD4 + T-cells Clinical Trials Gilead Sciences GS-1720 GS-4182 HIV Safety Study on Hold United States Food and Drug Administration +
FDA Places Clinical Hold on Five Gilead HIV Studies Due to Safety Concerns on June 11, 2025 Biktarvy CD4 + T-cell Clinical Trials Gilead Sciences GS-1720 GS-4182 HIV Lenacapavir Lymphocyte Count measurement safety signal Study on Hold United States Food and Drug Administration +